Opthea Reports Full-Year Financial Results and Business Updates
August 30, 2024
AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
June 7, 2021
Related Post
-
-
Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement
August 22, 2024
-
Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder
August 20, 2024
-
scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
August 12, 2024